Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immuron Ltd (IMC.AX)

Immuron Ltd (IMC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immuron Ltd Chapman Street Unit 10, 25-37 Melbourne VIC 3130 AUS

https://www.immuron.com.au P: +61 398245254 F: +61 398227735

Description:

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Key Statistics

Overview:

Market Capitalization, $K 22,780
Shares Outstanding, K 227,798
Annual Sales, $ 1,805 K
Annual Net Income, $ -3,787 K

Growth:

1-Year Return 28.21%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -0.42%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.02
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 11/17/14

IMC.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -20.01%
Return-on-Assets % -18.06%
Profit Margin % -209.81%
Debt/Equity 0.01
Price/Sales 6.37
Price/Book 1.30
Book Value/Share 0.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar